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Dexamethasone, a synthetic steroid, can be oxidized chemically to a ketonic steroid struc- 
ture that is readily -detected by electron capture negative ionization mass spectrometry 
(ECNIIMSI. Previous work from this laboratorv has demonstrated that the chemical oxida- 
tion procehure provides advantages of low detection limits and high selectivity for detection 
of oxidized dexamethasone against chemical background that would otherwise interfere with 
detection of this steroidal drug in biological samples using more conventional methodology. 
This report describes the extent to which tandem mass spectrometry (MS/MS) can further 
enhance the selectivity of the oxidationlECN1 methodology for the detection of dexametha- 
sone during the analysis of human plasma and presents evidence that sample introduction 
by direct inlet probe (DIP) can be used successfully under ECNI conditions. For purposes 
of comparing the methodologies, the same human plasma samples are analyzed by ECNI, 
first with detection by conventional mass spectrometry using selected ion monitoring (StM) 
and then by MS/MS -using selected reaction monitoring (%%I) with sample introdu&on by 
the eas chromatoaraohic (CC) inlet and bv the DIP. The results indicate that use of the 
DIP% a viable rnzah of iamble introduction for ECNI when sample processing involves 
the specialized oxidation procedure described herein because the sample matrix does not 
compete significantly for the thermal electrons in the ion source. Whereas SIM and SRM pro- 
vide comparable results when sample introduction is achieved by the GC inlet, the MS/MS 
approach offers the possibility for sample introduction using the DIP, which significantly 
simplifies and shortens the analysis. (J Am Sot Mass Spectrom 3990, I, 341-348) 
0 
ur goal is to develop sensitive and selec- 
tive, yet simple, methodology for the deter- 
mination of dexamethasone and other syn- 
thetic steroidal drugs in physiological fluids. We have 
demonstrated considerable success in this area by 
chemically oxidizing dexamethasone to a steroid struc- 
ture that has an approximate 100-fold increase in elec- 
trophilic character over that of the oxidation prod- 
ucts of most endogenous steroids [l]. Recent prelimi- 
nary results from a comparative study of the electron 
capture negative ionization (ECNI) response to unoxi- 
dized dexamethasone, as the tetra-TMS derivative, by 
gas-liquid chromatography (GLC) inlet and underiva- 
tired dexamethasone by direct inlet probe (DIP), ver- 
sus that of oxidized dexamethasone show an improve- 
ment of at least 25-fold by the latter [2]. The deter- 
mination of low concentrations of dexamethasone in 
complex biological matrices, such as plasma, requires 
sensitive and selective methodology. Although ade- 
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quately sensitive radioimmunoassays (RIA) for dexam- 
ethasone in plasma are available [3], cross-reactivity 
of the antibody can lead to dubious results. Gas 
chromatography/mass spectrometry (GUMS) meth- 
ods are more specific than RIA but not always as sensi- 
tive. The usual approach for GUMS determination of 
steroids in plasma involves extraction and purification 
of the steroids followed by derivatization to improve 
the chromatographic properties and thermal stability 
of the molecules. The most successful derivatization 
scheme of those reported for dexamethasone involves 
the formation of the 11,17,21-tris-trimethylsilyl ether- 
20-enol-trimethylsilyl ether (tetra-TMS). By using se- 
lected ion monitoring (SIM) GC/EIMS, Kasuya et al. 
[4] were able to detect an on-column injection of 100 
pg of dexamethasone-tetra-TMS [signal-to-noise (SIN) 
ratio of 2.51 from 1 mL of plasma spiked to a con- 
centration of 300 pg/mL. However, extensive isolation 
procedures, consisting of extraction by C-18 bonded- 
phase reverse-phase cartridge followed by normal- 
phase high-performance liquid chromatography purifi- 
cation, were necessary to eliminate the plasma ma- 
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trix interferences. In our hands, the detection limits 
claimed above could not be reproduced [5]. The meth- 
ods described here, which use the high electron cap- 
ture activity of the oxidized analyte for analysis by 
ECNIIMS, are more sensitive for the determination of 
dexamethasone in plasma than the Kasuya method. By 
using SIM and ECNIIMS, we were able to detect an in- 
jection of 30 pg of oxidized dexamethasone (SIN = 11) 
from 1 mL of plasma spiked with 209 pg of dexam- 
ethasone and 35 ng of internal standard. In addition, 
extensive isolation procedures are not required for our 
procedure [5], owing to the selectivity of the oxidation 
reaction and the ionization by electron capture. 
In an effort to further increase the selectivity of the 
oxidation-based assay with ECNI, we examined the 
possibility of using a triple quadrupole mass spectrom- 
eter (TQMS) for selected reaction monitoring (SRM). 
There have been reports of improvements by the tan- 
dem mass spechometry (MS/MS) approach to the de- 
tection of targeted compounds using ECNI with sam- 
ple introduction by GC [6-91. Recently, a quantita- 
tive assay for leukotriene-B4 (as the butyldimethylsilyl 
ether derivative) in synovial fluid was reported [lo]. 
The selectivity of ECNI in combination with MS/MS 
(i.e., ECNIISRM), allowed quantitation of lower levels 
of LTB4 in the matrix than would have been possible 
using ECNUSIM with a conventional single-stage mass 
spectrometer. 
This report compares results obtained by conven- 
tional mass spectrometry using a gas chromatograph 
as the inlet with results obtained by a TQMS using ei- 
ther a GC inlet or DIF’ for the analysis by ECNIiMSlMS 
of chemically oxidized extracts of human plasma for 
the determination of dexamethasone. Whereas the 
results described here indicate that SIM and SRM 
give comparable results when sample introduction is 
achieved by the GC inlet, the MS/MS approach does 
offer the possibility for sample introduction by means 
of the DIP system, which will significantly simplify and 
shorten the analysis by mass spectrometry. 
Experimental 
Znstrumentatiofl 
All data were collected on a Finnigan (San Jose, CA) 
TSQ-70 (triple-stage quadrupole) mass spectrometer 
equipped with a Varian (Walnut Creek, CA) 3400 gas 
chromatograph. Source conditions were established to 
maximize the abundance of the parent ion, M -, for 
analyses by MS/MS. The molecular anion of the ox- 
idized dexamethasone was at the greatest absolute 
abundance when ammonia was used as the ECNI 
modifying gas at a pressure of about 1 torr. The elec- 
tron energy was 100 eV, and the primary electron beam 
current was 300 PA. The ion source temperature was 
maintained at 100 “C. For analyses by SIM, the ion 
source was maintained at 120 ‘C in order to obtain a 
greater abundance of the fragment ion, m/z 310, which 
was used for quantitation. 
Gas Chromatography. Samples were mtroduced into 
the ion source via a DB-5 capillary column (30 mx0.25 
mm, J&z W Scientific, Folsum, CA) directly interfaced to 
the mass spectrometer. Helium was used as the car- 
rier gas at a flow rate of 1 mllmin. The column was 
operated with a splitless injector and, following an in- 
jection, the GC oven temperature was ramped from 60 
or 120 “C to 260 “C at 40 ‘C/mm and from 260 “C to 
280 “C at 4 “Clmin. 
Direct Probe. Samples were introduced into the ion 
source via the DIP system on the TSQ-70 instrument. 
After insertion of the probe, the temperature was 
ramped from 35 to 200 “C at a rate of 70 “Clmin and 
held at 200 “C for 2 min. 
Collision Energy and Pressure Studies 
The conditions for the MS/MS experiments were opti- 
mized by varying both the collision gas pressure and 
collision energy. Conditions were sought that would 
provide greatest detection of the daughter ion current 
at m/z 310. For these studies, 3.56 ng of oxidized dex- 
amethasone was introduced by the DIP. The probe 
was held at 40 “C for 1 min and then ramped to 200 
“C at 30 “Clmin and held at 200 “C for 2 min. This 
temperature program yielded a level plateau region in 
the desorption profile over which the total ion current 
(TIC) was relatively constant. Over the course of this 
constant TIC region, repetitive daughter ion spectra of 
m/z 330 were obtained at different energies. The par- 
ent ion current at m/z 330 was selected by the first 
quadrupole (Q1), and the third quadrupole (Qs) was 
scanned from m/z 275 to m/z 345 at 0.1 s/scan. (The full 
daughter spectrum indicated no fragments below m/z 
275.) Consecutive daughter ion scans were acquired at 
collision energies of 1, 3, 5, 12, and 25 eV; this cycle 
was repeated many times over the course of the des- 
orption profile. Five scans at each collision energy, col- 
lected during the period of relatively constant parent 
ion current in the desorption profile, were averaged 
to provide a representative daughter ion mass spec- 
trum. Replicate experiments were performed for each 
collision gas pressure. This protocol permitted a re- 
liable assessment of the fragmentation and collection 
efficiency as a function of collision energy at a given 
pressure of collision gas in Q2, An argon pressure of 
approximately 1.3 mtorr and a collision energy of 4 
eV were chosen for the analysis of plasma extracts by 
SRM. This unusually low value of collision energy was 
chosen because it yielded maximal intensity at m/z 310 
as discussed in the Results and Discussion section. 
SZM and SRM Studies 
For the determinations of dexamethasone in plasma 
by SIM, Qr was operated in the normal mass spectro- 
metric scan mode while QZ and Qs were maintained 
in the rf-only mode. Ion currents at m/z 339.2, 319.2, 
330.2, and 310.2 were monitored with 0.8-u windows. 
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The dwell time was 50 ms at each mass window. The 
electron multiplier was set at 1200 V. 
For the analyses by SRM, the ion currents corre- 
sponding to the reactions m jz 330 --t m/z 310 (for oxi- 
dized dexamethasone) and m/z 339 -+ m/z 319 (for ox- 
idized 13C6, 2Hs-dexamethasone) were monitored with 
a 1.0-u window. Dwell times were 50 ms. The electron 
multiplier was set at 1400 V. 
Materials 
Chemicals used for the oxidation procedure in- 
clude pyridinium chlorochromate (Aldrich Chemical 
Co., Milwaukee, WI) and anhydrous sodium ac- 
etate (J. T. Baker Chemical Co., Phillipsburg, NJ). 
All solvents used were either analytical or HPLC 
grade, purchased from Burdick and Jackson Divi- 
sion of Baxter Healthcare Corporation (Muskegon, 
ML), J. T. Baker Chemical Company, (Phiips- 
burg, NJ), EM Science (Gibbstown, NJ), and Mal- 
hnckrodt, Inc. (St. Louis, MO). Celite analytical filter 
aid was purchased from Fisher Scientific Co. (Pitts- 
burg, PA). Analytical reagent urea was purchased 
from Maliinckrodt (St. Louis MO). C-18 PrepSep 
solid-phase extraction columns (200 mg) were pur- 
chased from Fisher Scientific. Silica solid-phase ex- 
traction columns (500 mg) were purchased from Bur- 
dick and Jackson Division of Baxter Healthcare Cor- 
poration (Muskegon, MI). Dexamethasone was pur- 
chased from Steraloids, Inc. 1,2,3,4,5, 19-13 G, 19,19,19- 
2H3-dexamethasone was a gift from Clinton Kilts of 
the Department of Pharmacology at Duke University. 
All materials were used without further purification. 
Silanized glassware was used throughout the proce- 
dures. 
Methods 
Sample preparation based on the oxidation method 
consists of three steps: plasma extraction, chemical ox- 
idation, and removal of excess oxidation reagent. 
Extraction of Plasma Samples 
Samples consisted of 1.5 mL of plasma taken from 
patients at various times following administration of 
1 mg of dexamethasone. Before extraction, 35 ng of 
‘3Cg,2Hs-dexamethasone in 50 PL of methanol was 
added to each sample. Solid-phase extraction columns 
containing 200 mg of C-18 packing were precondi- 
tioned with 5 mL of an 8 M aqueous urea solution to 
deactivate active sites, followed by washes with 5 mL 
of methanol and 10 mL of distilled water. The plasma 
samples were applied to the columns followed by 
washes with 4 mL distilled water and then 4 mL of 15% 
done by gravity flow to avoid contamination from the 
vacuum manifold. 
Oxidation of Plasma Extracts 
Following removal of the eluting solvent by evapora- 
tion under a stream of nitrogen, 1 mL of CHzClz was 
added to each residue with magnetic stirring to pro- 
mote dissolution of the extracted material. Approxi- 
mately 10 mg of anhydrous sodium acetate was added 
to the reconstituted solutions of the extracts; sodium 
acetate was added to buffer acid liberated during the 
oxidation. An excess of pyridiium chlorochromate, 
finely ground with Celite (ca. 1:3 w/w) by using a mor- 
tar and pestle, was then added to the solutions. The 
reaction mixtures were stirred and heated to 60 “C for 
6.5 h. 
Removal of Oxidation Reagent 
Solid-phase extraction columns containing 500 mg of 
silica were prewashed with several column volumes of 
CHrClr. After completion of the oxidation, the reac- 
tion mixtures were transferred directly to the columns, 
which were then washed with 1.5 mL of CH2C12. The 
oxidation product of dexamethasone was eluted with 
4 mL of 5% acetone in CHzClz. After removal of the 
5% acetone-CHzClz under nitrogen, the residue was 
redissolved in 100 rL of ethyl acetate. Aliquots of l-3 
PL were required for analysis by ECNI with GUMS, 
GCIMSIMS, or DIPIMSIMS. 
Preparation of Calibration Curve 
As an internal standard, 35 ng of 13C6,2Hs- 
dexamethasone was added to each of several 1-mL 
aliquots of Red Cross Blood Bank plasma. Following 
addition of the internal standard, dexamethasone was 
added to the 1-mL aliquots in amounts of 0.0 (blank), 
0.209, 0.418, 1.67, 4.18, 8.36, and 16.7 ng of dexa- 
methasone in 25-100 pL of methanol. Each standard 
was prepared in duplicate. The extraction, oxidation, 
isolation, and analysis procedures for these standards 
were identical to those used for the clinical plasma 
samples. 
Determination of Accuracy and Precision 
Two aliquots of 1 mL of blood bank plasma were 
“spiked” with 35 ng of 13Q,ZH3-dexamethasone and 
2.09 ng of dexamethasone. These duplicate standards 
were processed independently and analyzed in trip- 
licate by ECNIiMS with GUMS, GCIMSIMS, and 
DIPIMSIMS to assess the accuracy and precision of the 
determination of dexamethasone by these techniques. 
methanol in water. Dexamethasone was eluted with 
4 mL of 70% methanol in hexane. All solvents were 
Results and Discussion 
forced through the solid-phase extraction columns at Dexamethasone is a synthetic corticosteroid drug that 
flow rates of about l-2 drops/s by the use of a vac- contains one fluorine atom. The structures of dex- 
uum manifold, except for the final elution, which was amethasone and its oxidized 11,17-keto analogue are 
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Dexamethasone 
pigure I. Conversion of dexamethasone 
to its 11,17-k&o analogue by chemical 
oxidation. 
~nw~l~met~11fi17Q21- fdol-, ,4-pregnaden-32Odione)) 
depicted in Figure 1. Epimerization of the I&-CHs 
group occurs during the oxidation procedure, produc- 
ing about 20% of the 16&CHs epimer of the oxida- 
tion product, 9a-fluoro-16-methyl-1,4-androstadiene- 
3,11,1Pbione (11,17-keto-dexamethasone). The ECNI 
spectrum of 11,17-keto-dexamethasone consists pri- 
marily of a peak at m/z 330 for the molecular anion and 
a base peak at m/z 310 representing the [M-HF]-’ ion. 
A loss of HF is characteristic of compounds containing 
a fluorine atom. 
When the molecular anion of 11,17-keto dexametha- 
sone is chosen as the parent ion and subjected to colli- 
sion with argon in Qz, the predominant fragment is, as 
expected, [M - I-IF-‘. The daughter ion spectrum ob- 
tained by coilision-activated dissociation (CAD) of the 
molecular anion is shown in Figure 2. Few endoge- 
nous compounds contain fluorine; therefore, mterfer- 
ing substances from the plasma matrix are unlikely to 
undergo a neutral loss of 20 u (loss of I-IF). Minor peaks 
are observed at m/z 295 and m/z 280, which represent 
[M - HF -CH$ and [M -HZ - 2CHs]‘-, respectively. 
Because the loss of HF is specific for the fluorine- 
containing oxidized dexamethasone, CAD conditions 
were sought that would maximize the detection of ion 
current at m/z 310. 
Optimimtioon of MS/MS Parameters 
Two essential MS/MS parameters affecting fragmenta- 
tion efficiency, BF i /(XF i + P), and collection efficiency, 
(XF; + P)/Po, where CFi is the sum of the fragment 
ion intensity, P is the remaining parent ion intensity, 
and PO is the parent ion intensity without collision gas, 
are collision gas pressure and collision energy. Several 
310 
280 290 300 310 320 330 
m/z 
Figure 2. Daughter ion spechwm of the molecular anion of 11,17- 
keto-dexamethasoe by CAD [4 eV (Lab), 1.3 mtom argon]. 
16P-methyl-i l,l7-keto 16c-methyl-11 ,I 7-keto 
Dexamethasone Dexamethasone 
@=4kar~16pm~hy~la- 
*nbostad,ens_3,,1,17_trirmy 
k3a-lwm-lbl.memycl,~ 
androstadienea.l1,17-trio"*, 
experiments were designed to dissect out interactive 
parameters of the CAD process that could be adjusted 
individually. 
The ion collection efficiency was assessed as a func- 
tion of collision energy by the experimental protocol 
described above. The reconstructed TIC, shown in Fig- 
ure 3a, is presented as a function of coILsion energy at 
argon pressures of 0.4, 0.9, and 1.3 mtorr in Qs. When 
argon was present at 0.4, 0.9, and 1.3 mtorr in Q2, 
the collection efficiency decreased at collision energies 
above 3 eV; similar attenuation of the TIC at higher col- 
lision energy has been noted by other researchers [lo]. 
The poorest collection of ions is observed at the low- 
est energy examined, 1 eV; this is apparently due to 
the low kinetic energy of the parent ion. The highest 
cdlection efficiency occurred with a collision energy 
of 3 eV for each pressure examined. The value for the 
25 - 
I”020 - 
&5- 
0.4 mtorr Ar 
s 
qio - 0.9 mtorr Ar 
0 5 10 15 20 25 
Collision Energy, eV (Lab) 
@I 
Figure 3. (a) Reconstructed TIC from CAD of the M’- of ox- 
idized dexamethasone as a function of collision energy at dif- 
ferent collision gas (argon) pressures in Qz. (b) Magnitude of 
[M - HF]' - daughter ion (m/z 310) current as a function of col- 
lision energy at three pressures of argon in Q2. 
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maximum TIC at 3 eV was approximately the same for 
the three pressures of argon except at 1.3 mtorr, where 
there was a slight attenuation of the ion beam (about 
15%) due to higher collision gas pressure, and when 
Q2 was empty. We have no reasonable explanation for 
the TIC results from experiments with no collision gas 
in Q2 being lower than those when Q2 is pressurized 
at collision energies below 5eV; the precision of re- 
sults ( i 15% relative standard deviation) is too poor, 
because of the experimental difficulties in obtaining 
TIC as a function of both energy and pressure, to dis- 
tinguish individual values at low energy in Figure 3a. 
Energy effects at 2 mtorr also were examined; consid- 
erable reduction in the collection efficiency occurred 
(about 45%) relative to that at other pressures exam- 
ined (data not shown). In contrast, when the collision 
cell is empty, a relatively constant ion flux is detected 
from 3 eV to 25 eV, with greatest transmission at 25 
eV. 
decrease in collection efficiency as collision energy is 
raised. 
The magnitude of fragment ion current at m/z 310 as 
a function-of collision energy is represented in Figure 
3b. At the lowest pressure, 0.4 mtorr argon, collision 
at 25 eV provides the greatest amount of [M-l-IF]‘-. 
At increased pressures, lower energies were required 
for maximal formation of [M - HF]‘-; optimal energy 
for CAD at 0.9 mtorr and 1.3 mtorr was 5 eV. More ef- 
fective transfer of kinetic energy to internal energy oc- 
curs with higher collision frequency [ll, 14, 151; thus, 
less translational energy is required at higher gas pres- 
sures than at low pressure to induce similar fragmen- 
tation. Secondary dissociation of [M - HF]‘- also may 
occur at higher pressures; successive losses of CH3’ 
from [M - HF].- result in formation of ions of mass 
295 and 280. Peaks at m/.z 295 and m/z 280 increase in 
intensity as the collision energy is raised at pressures 
of 0.9 and 1.3 mtorr, whereas the intensity at m/z 310 
decreases for [M - HF]‘-. The interdependency of various instrumental pa- 
rameters involved in an MS/MS experiment makes it 
difficult to determine what causes the decrease in col- 
lection efficiency as collision energy is raised. Of the 
several variables, greater collision energy increases the 
fragmentation efficiency, and these daughters may be 
confined with varying degrees of efficiency in the rf- 
only field of Q2 [ll, 121. Mass-discriminatory effects 
are generally pronounced when the daughter ion mass 
is much lower than the parent mass. In this case, how- 
ever, the daughter mass (m/z 310) is 94% of the parent 
mass (m/z 330); therefore, losses due to disparities in 
efficiency of ion containment in Q2 should be mini- 
mal. Variations in the transmission of ions as a func- 
tion of collision energy have been noted by Alexan- 
der and Boyd [12] for a hybrid BEQQ instrument. In 
their study, the maximum and minimum transmission 
of protonated Leu-enkephalin (MHC , M/Z 556), with- 
out collision gas present, varied by a factor of 2 over 
the collision energy range of K-30 eV [12]. Fluctua- 
tions in the transmission curve for both parent and 
daughter ions as Ebb increases could account for the 
apparent losses of ion current. However, in our case 
with Q2 empty, the constant parent ion flux, which is 
quite independent of collision energy, would seem to 
indicate that our losses are not due to an inshumen- 
tal dependency similar to that of Alexander and Boyd. 
Thus, by default, target gas pressure factors appear to 
cause the decrease in collection efficiency as J&b in- 
creases. Scattering of both parent and daughter ions 
may lead to lower transmission into the acceptance re- 
gion of Qg [13], but the tandem quadrupole configura- 
tion is generally considered to be a good focusing de- 
vice for scattered ions, so scattering losses are probably 
minor. With increased pressure and higher energies, 
collision-induced electron detachment [14] may com- 
pete with the CAD processes, resulting in formation 
of undetectable neutral species. All factors described 
probably contribute to ion losses, but electron detach- 
ment is-most likely the predominant factor causing the 
As a result of the optimization studies, a pressure 
of approximately 1.3 mtorr argon in Q2 and a collision 
energy of 4 eV were employed to ensure both high ion 
collection efficiency and extensive fragmentation of the 
parent ion of mass 330, resulting in optimal detectabil- 
ity of the daughter ion of mass 310 during the analysis 
of plasma samples. 
SR.M vs. SIM 
The improved selectivity of GClSRM over GClSIM is 
shown in Figure 4, which is a composite of results 
from the analysis of a plasma extract for dexametha- 
sone. Shown in Figure 4a are the selected ion cur- 
rent profiles for the M’- and [M - HF]‘- of 11,17- 
keto-dexamethasone (top two panels) and 11,17-keto- 
13Cs,2H3-dexamethasone (bottom two panels); the lat- 
ter was used as an internal standard during analy- 
sis of this plasma sample by SIM. These data were 
obtained after the extraction and oxidation of a 1.5- 
mL plasma sample containing 35 ng of internal stan- 
dard and 0.9 ng of dexamethasone (concentration of 
0.6 nglmL). The quantities injected on-column to ob- 
tain the data in Figure 4a correspond to approximately 
20 pg of oxidized dexamethasone and 0.7 ng of the 
oxidized isotopically labeled dexamethasone. Shown 
in Figure 4b are the selected reaction current profiles 
obtained from another aliquot of the same sample as 
analyzed by GClSRM with CAD of the molecular an- 
ions of 11,17-keto-dexamethasone (top panel) and the 
13Cs,2H3-11,17-keto internal standard (bottom panel). 
In Figure 4b, all the interfering ion current has been 
eliminated by the MS/MS process. The only signal 
present is that from the 11,17-keto-dexamethasone and 
its 16/3-CH3 epimer (peak at longer retention time). The 
absence of background makes the determination of the 
peak height or the integration of the peak area straight- 
forward and increases the precision of replicate anal- 
yses. Determination of the baseline position for peak 
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Selected ion current profiles 
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Figure 4. Comparison of selected ion current profiles obtained by 
GCiECNI with (a) selected ion monitoring (top two panels for ox- 
idized dexamethasone; bottom two panels for internal standard) 
and (b) selected reaction monitoring (top panel for oxidized dex- 
amethasone; bottom panel for internal standard). 
height or area measurement from the SIM data in Fig- 
ure 4a is more arbitrary, which leads to poorer preci- 
sion than that in GCISRh4. 
Comparison of the calibration curves obtained by 
SIM and by SRM, shown in Figure 5, indicates that the 
limits of detection (LOD) of dexamethasone in plasma 
by the three techniques are identical. The LOD can be 
defined as the concentration of analyte giving a detec- 
tor response that is three times the standard deviation 
of the analytical result for the blank; alternatively, the 
value of the y intercept of the calibration curve can 
be used in place of the analytical result for the blank 
in calculating the LOD 1161. Using this criterion, the 
LOD of dexamethasone in plasma was 0.25 nglmL by 
SIM (yint = 0.026, s = 0.0030), 0.31 ng/mL by GC/SRM 
(ylTlt = 0.029, s = 0.0035), and 0.33 ng/mL by DIP/SE&l 
(yint = 0.039, s = 0.0033). It is likely that these LODs 
could be decreased by decreasing the amount of in- 
ternal standard that is added to the samples. A large 
amount of ‘3C&2Ha-dexamethasone was added to the 
plasma samples to serve as a carrier as well as the inter- 
nal standard. The isotopically labeled internal standard 
contained about 3% unlabeled dexamethasone, which 
resulted in a high blank value. This high blank appar- 
ently resulted from contamination of the internal stan- 
dard prior to its use in these analyses; the blank value 
in 13c 6,2H3-dexamethasone should be vanishingly low. 
The high blank was not caused by the oxidation proce- 
dure, as a high blank was also observed with conven- 
tional EI methodology by the group donating the iso- 
topicarly labeled material. The detection limit of this as- 
say is limited by the precision with which we can mea- 
sure the blank as well as the low slope of the calibration 
curve. The addition of less internal standard should 
result in a steeper slope for the calibration curve. An 
experiment was done to determine whether the LOD 
for dexamethasone in plasma could be decreased by 
the addition of less internal standard. Standards for 
a calibration curve were prepared as described in the 
Experimental section except that one tenth the quan- 
tity of internal standard was added to each standard. 
The limits of detection calculated (as described pre- 
viously) from the calibration curves obtained during 
analyses of these standards by GCiSIM and GCPSRM 
were 0.15 ng/mL and 0.05 ng/mL, respectively. The 
lower value for GClSRM derives from the better preci- 
sion available from SRM as explained earlier. Peak ar- 
eas for m/z 310 obtained by GCiSRM from standards 
containing the same amount of dexamethasone indi- 
0 5 10 15 20 
ng/ml of dexamethasone 
“.I 
0 5 10 15 20 
nglml of dexamethabone 
@b) 
-% ~~o-_o 
ng/ml of dexamethasone 
(C) 
Figure 5. Calibration curves for the determination of dexametha- 
sane in plasma by (a) GClECNllMS with selected ion monitoring, 
(b) GClECNUMSiMS with selected reaction monitoring, and (c) 
DIPlECNIiMSlMS with selected reaction monitoring. The quan- 
tities introduced into the ion source represent a range of 4-200 
pg of dexamethasone and 700 pg of internal standard. 
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cated no decrease but small and large amounts of in- 
ternal standard indicated no decrease in the recovery 
of dexamethasone when the smaller amount of inter- 
nal standard was used. Therefore, the smaller amount 
of internal standard is recommended. In the compar- 
ison described above, the LOD for GClSIM may be 
high because Slh4 was carried out in the TSQ70 with 
Qz and Q3 in the rf-only mode, a feature that reduces 
overall ion transmission by an order of magnitude or 
more compared to that of a single quadrupole instru- 
ment. This was not considered a serious problem, as 
the central thrust of this report focuses on selectivity 
and not sensitivity. 
Several plasma samples from patients undergo- 
ing the dexamethasone suppression test were ex- 
tracted, oxidized, and analyzed by GClSIM and by 
both GClSRM and DIPISRM. The quantitative results 
are shown in Table 1 together with standard devia- 
tions that indicate the level of instrumental precision. 
The results by SIM and SRM with sample introduc- 
tion by GC are in good agreement with the exception 
of those for sample P3. The results obtained by SRM 
with sample introduction by DIP do not differ signif- 
icantly from those obtained with sample introduction 
by GC, with the exception of those for samples P3 
and P5. GCfSRh4 is the most selective of the three an- 
alytical techniques, because interferences are excluded 
by both the GC inlet and MS/MS. Therefore, the re- 
sults obtained by GCISRM would be expected to be 
the most reliable. 
Other researchers have reported that a chromato- 
graphic step in the sample preparation is necessary 
in methodology based on ECNIlMSlMS when a gen- 
eral derivatization reagent is used to prepare an elec- 
trophilic derivative of the sample [7]. The chromato- 
graphic step is required because the electron capture 
cross sections of many matrix components also are 
enhanced by the derivatization. The derivatized ma- 
trix components can deplete the concentration of ther- 
mal electrons in the ion source [7, 171. Without suffi- 
Table 1. Comparison of GC/ECNI/SIhJ, GCIECNIISRh4, 
and DIPIECNIISRM for the determination of dexametha- 
sone in plasma 
Sample GC/SI M GC/SRM DIPISRM 
P2 0.63*0.07 (n=Z) 0.76ztO.01 0.68kO.03 &1=4) 
P5 0.62rtO.09 0.69*0.02 0.35*0.01 
PI1 3.2zt0.4 (n=2) 4.0*0.4 4.4* 0.4 
P18 30*4 [n=2) 36k3 35* 1 
P31 0.18rkO.01 ln=4) 0.29*0.01 0.15*0.01 
7Ab 2.1 eo.1 1.9*0.1 2.11+0.05 
7Bb 1.8fO.l 1.82kO.04 - 
Concentrations are reported in nglmL of plasma & one standard 
deviation. Number of replicate injections In) is 3 unless indicated as 
otherwise. 
a The values listed for GC/SIM and DWSRM fall below the LOD. 
’ Duplicate spiked plasma sample (2.09 nglmL). measured in triplicate. 
cient chromatographic separation, the low level of an- 
alyte present in the ion source apparently cannot com- 
pete effectively with the overwhelming excess’of elec- 
trophilic components of the matrix for the pool of ther- 
mal electrons. However, the chemical oxidation proce- 
dure described herein selectively converts the analyte 
to an electrophilic analogue without greatly enhancing 
the electrophilic character of the matrix. Therefore, in- 
troduction of an oxidized sample by direct probe is 
viable, because the matrix is less likely to participate 
in ECNI, and thus, in most cases, it does not hinder 
detection of the analyte by ECNI. 
Conclusions 
The use of selected reaction monitoring for the detec- 
tion of oxidized dexamethasone in a plasma matrix un- 
der ECNI conditions yields results similar to those ob- 
tained through the use of SIM. When the GC inlet is 
used, SRM offers no significant advantage over SlM 
due to the selectivity already achieved by the chem- 
ical oxidation procedure and subsequent ECNI. The 
additional selectivity of SRM allows the direct probe 
sample inlet to be used successfully for analyses based 
on ECNI. Of significant importance is the fact that the 
nonelectrophilic sample matrix accompanying the ox- 
idized analyte, as prepared by the specialized chemi- 
cal oxidation procedure described herein, reduces the 
possibility of quenching the ECNI of the analyte during 
batch introduction of the sample by the direct probe. 
An investigation of the effect of structural features on 
the ECNl response of steroids and cyclic compounds 
is being pursued. 
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